From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

A share tip from Tom Winnifrith, The Mark Slater show video, a 1 billion fraud & more problems for Julie Meyer

By Tom Winnifrith | Friday 4 May 2018


 


And that is just part of today's content here on ShareProphets. Coming up later there are 2 more buy tips, 5 more videos a cracking bearcast and much more. But....

Some of this content (Slater, the bearcast, my share tip) are for paying customers only. £5.99 a month is justified on today's output alone!

You could of course pay nothing and enjoy 3 free articles a month, but not Slater, my share tip or any bearcasts, nor for that matter Luke Johnson over the weekend or the bears Matt Earl & Lucian Miers at UK Investor or... well that would be telling.

In breaking the 1 billion fraud overnight this website again showed the guts that the mainstream press do not have. We have cojones the FT et al have no balls at all.

Don't miss out on our premium content and support our great fraud busting at the same time... all for less than the cost of one glass of wine. Sign up for immediate access HERE

Tom Winnifrith

This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:29:22